期刊文献+

头孢噻利对铜绿假单胞菌和甲氧西林耐药金葡菌的体外抗菌作用研究 被引量:1

Synergistic antibacterial effect of cefoselis against Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus
下载PDF
导出
摘要 目的探讨头孢噻利与阿米卡星对铜绿假单胞菌及头孢噻利与万古霉素对MRSA的体外联合抗菌作用,为联合抗菌治疗提供依据。方法收集30株不同耐药表型的铜绿假单胞菌和30株耐甲氧西林的金葡菌(MRSA),采用棋盘法测定头孢噻利与阿米卡星、头孢噻利与万古霉素的联合抗菌作用。结果头孢噻利与阿米卡星联合对铜绿假单胞菌具有协同、相加和无关作用者分别占26.7%、40.0%和33.3%。头孢噻利与万古霉素联合对MRSA主要是相加作用(63.3%),其余为无关作用(36.7%)。两组细菌中均未发现拮抗现象。结论头孢噻利与阿米卡星对铜绿假单胞菌及头孢噻利与万古霉素对MRSA在体外均表现出较好的联合抗菌作用。 Objective To evaluate the in vitro activity of cefoselis in combination with amikacin against Pseudomonas aeruginosa and cefoselis in combination with vancomycin against methicillin-resistant Staphylococcus aureus(MRSA) to help clinicians choose better empirical combination therapy.Methods Checkerboard assay was used to determine the synergistic antimicrobial effect of cefoselis plus amikacin against 30 strains of P.aeruginosa,and cefoselis plus vancomycin against 30 strains of MRSA.Results Cefoselis plus amikacin showed effect of synergy,addition and indifference against 26.7%,40.0% and 33.3% of the 30 P.aeruginosa strains,respectively.Cefoselis plus vancomycin demonstrated effect of addition and indifference against 36.7% and 63.3% of the 30 MRSA strains.No antagonism was observed.Conclusions Cefoselis in combination with amikacin has some synergistic effect against P.aeruginosa,while cefoselis in combination with vancomycin demonstrates additive effect against some MRSA strains.
出处 《中国感染与化疗杂志》 CAS 2011年第4期264-267,共4页 Chinese Journal of Infection and Chemotherapy
关键词 铜绿假单胞菌 甲氧西林耐药金黄色葡萄球菌 头孢噻利 联合抗菌 棋盘法 Pseudomonas aeruginosa methicillin-resistant Staphylococcus aureus cefoselis synergistic effect checkerboard assay
  • 相关文献

参考文献8

  • 1徐德斌,张劭夫,公衍文,华树成,石永兵,李英,刘华.注射用头孢噻利治疗急性细菌感染的多中心双盲随机对照临床研究[J].中国感染与化疗杂志,2010,10(3):172-175. 被引量:5
  • 2Fish DN, Choi MK, Jung R. Synergic activity of cephalospo tins plus fluoroquinolones against Pseudomonus aeruginosa with resistance to one or both drugs[J]. J Antimicrob Che mother,2002,50(6) : 1045-1049.
  • 3Oie S, Uematsu T, Sawa A, et al. In vitro effects of combi nations of antipseudomonal agents against seven strains of multidrug resistant Pseudomonasaeruginosa [J]. J Antimicrob Chemother, 2003, 52(6):911-914.
  • 4Totsuka K, Shiseki M, Kikuchi K, et al. Combined effects of vancomycin and imipenem against methicillin resistant Staphylococcus aureus (MRSA) in vitro and in vivo[J]. J Antimi crob Chemother, 1999, 44(4): 455-460.
  • 5Fu KP, Foleno BD, 1.afredo SC, et al. In vitro and in vivo antibacterial activities of FK037, a novel parenteral broad spectrum cephalosporin[J]. Antimierob Agents Chemother, 1993, 37(2): 301-307.
  • 6Eliopoulos GM. Synergism and antagonism[J] Infect Dis Clin North Am, 1989, 3(3) :399-406.
  • 7Lozniewski A, Lion C, Mory C, tween cefepime and vancomycin et al. In vitro synergy be against methicillin-suscepti hie and resistant Staphylococcus aureus and Si:aphylococcus epidermidis [J]. J Antimicrob Chemother, 2001, 47 (l) : 83-86.
  • 8Kazuo H,Yoshimi W, Yasuyuki H, et al. The therapeutic effect of combined vancomycin and cefoselis against murine pneumonia caused by methicillin resistant Staph.ylococcus au reus in and in vivo pharmacokinetic model[J]. J Chemother, 1996,44(4) :213-219.

二级参考文献4

  • 1黄朋勉,王磊,范小鹏,李江胜,陈立功,谢伟胜.硫酸头孢噻利的合成研究进展[J].精细化工中间体,2007,37(1):15-18. 被引量:3
  • 2Giamarellos-Bourboulis EJ,Grecka P,Tsitsika A,et al.In-vitro activity of FK 037 (Cefoselis),a novel 4(th) generation cephalosporin,compared to cefepime and cefpirome on nosocomial staphylococci and gram-negative isolates[J].Diagn Microbiol Infect Dis,2000,36(3):185-191.
  • 3Climo MW,Markowitz SM,Williams DS,et al.Comparison of the in-vitro and in-vivo efficacy of FK037,vancomycin,imipenem and nafcillin against staphylococcal species[J].J Antimicrob Chemother,1997,40(1):59-66.
  • 4周宇麒,张天托.第4代广谱头孢菌素:头孢噻利研究进展[J].中国药房,2002,13(12):753-754. 被引量:33

共引文献4

同被引文献11

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部